Unknown OBSERVATIONAL NCT03007082

Revive AIS Patients ImmeDiately (RAPID)

A Multicenter, Prospective Registry Clinical Study of the Effectiveness and Safety of ReVive SE Thrombectomy for Acute Ischemic Stroke

Sponsor: Changhai Hospital

Conditions Ischemic Stroke Occlusion, Cerebrovascular

Interventions Revive SE intracranial thrombectomy device

Updated 8 times since 2017 Last updated: Jan 5, 2017 Started: Nov 30, 2016 Primary completion: Feb 28, 2018 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03007082, this observational or N/A phase trial focuses on Ischemic Stroke and Occlusion, Cerebrovascular and remains ongoing. Sponsored by Changhai Hospital, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Feb 2019 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Feb 2019 [monthly]

Recruiting

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changhai Hospital

Data source: Changhai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China